Skip to content

Clinical trials

Esophageal Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Country / region: South Korea Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20111
20131
20141
20153
20163
20174
20183
20194
20208
20215
20225
20234
20245
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting15
Unknown status12
Active, not recruiting9
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Samsung Medical Center5
Jazz Pharmaceuticals3
Novartis Pharmaceuticals3
Asan Medical Center2
AstraZeneca2
Hoffmann-La Roche2
Pfizer2
Yonsei University2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms58
Stomach Neoplasms27
Ovarian Neoplasms16
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms12
Pancreatic Neoplasms10
Squamous Cell Carcinoma of Head and Neck10
Neoplasms9
Uterine Cervical Neoplasms9
Breast Neoplasms8

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.